Skip Navigation



NDT Advance Access published online on October 27, 2007

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfm580
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/1/288    most recent
gfm580v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mahdavi-Mazdeh, M.
Right arrow Articles by Nafar, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahdavi-Mazdeh, M.
Right arrow Articles by Nafar, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran

Mitra Mahdavi-Mazdeh1,2, Mahnaz Zamyadi3 and Mohsen Nafar4

1Department of Nephrology, Medical Sciences, Tehran University, 2Director of Management Center of Transplantation and Special Diseases-MOH, Tehran, 3Transplantation and Special Diseases Center (MOH) and 4Department of Nephrology –Shahid Beheshti University of Medical Sciences, Iran

Correspondence and offprint requests to: Mitra Mahdavi-mazdeh, Associate professor of Nephrology, Medical Sciences, Tehran University, Tehran, Iran. Email: mmahdavi{at}tums.ac.ir



  Abstract

Background. Chronic kidney disease (CKD) and end-stage renal disease (ESRD) are emerging as globally important public health problems, and will necessitate improvements in health-care policy. ESRD incidence/prevalence data are not available from large parts of the developing world. The main objective of this study is to describe and assess the current clinical practices for patients on maintenance haemodialysis (HD) living in the province of Tehran.

Methods. In December 2005, an observational study was performed with 2630 patients (1505 males and 1125 females) from 56 different centres in the province of Tehran (the entire HD population), which has a population of 13.5 million inhabitants.

Results. The prevalence/incidence of HD was 194.8/77.3 p.m.p. The leading causes of ESRD were diabetes and hypertension. Population of 90.3 and 9% received three and two sessions per week, respectively, with a KT/V mean value of 0.97 ± 0.25. All centres used synthetic membranes, and 68% of the sessions were performed using bicarbonate as a buffer. The type of vascular access was autogenous arteriovenous fistula in 91% of patients.

Our findings indicated that compliance with the K/DOQI recommendations for calcium–phosphorus management is difficult to achieve. Only 1.8% of patients achieved all four target laboratory tests.

For the management of anaemia, ferritin was the most commonly performed measure of iron status (76.7%). Iron deficiency was seen in <20% of patients (ferritin ≤200) and the mean value of haemoglobin (Hb) was 10.14 ± 2.00 g/dl.

Conclusion. The achieved standard of renal replacement therapy (RRT) in Tehran province, Iran is acceptable and in some aspects is comparable with European countries, but the number of ESRD patients is increasing in Tehran and worldwide. Increases in the number of HD centres, machines, shifts and kidney transplantations are taking place but cannot keep pace with the increasing number of patients. It is highly recommended that we try to increase peritoneal dialysis (PD) coverage and cadaveric transplantation, while keeping in mind that the prevalent population of individuals with CKD is estimated to be at least 20 times the number with ESRD.

It is not too ambitious to consider CKD prevention, and we should place initial focus on strategies and treatments that slow disease progression, in order to postpone RRT.

Received for publication: 4. 2.07
Accepted in revised form: 31. 7.07


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.